{
    "2021-05-11": [
        [
            {
                "time": "2021-05-11",
                "original_text": "复星医药(600196)重大事项点评：与BIONTECH成立JV 打造全球领先的mRNA技术平台",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BIONTECH",
                        "JV",
                        "mRNA技术平台"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "复星医药(600196.SH)：复宏汉霖就BRAFV600E抑制剂与润新生物签订许可协议",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "BRAFV600E抑制剂",
                        "润新生物",
                        "许可协议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "【权益变动】复星医药(02196.HK)获摩根大通增持677.1531万股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "摩根大通",
                        "增持"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "北向资金今日净流出47.81亿元 五粮液获净买入6.44亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流出",
                        "五粮液",
                        "净买入"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "策略日报：指数震荡分化 资源类板块领涨",
                "features": {
                    "keywords": [
                        "指数",
                        "震荡分化",
                        "资源类板块",
                        "领涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资源类"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "东吴证券维持复星医药买入评级：拟与BioNTech投资设立合资公司 长期看好mRNA新冠疫苗市场前景",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "复星医药",
                        "BioNTech",
                        "合资公司",
                        "mRNA新冠疫苗",
                        "市场前景"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "瑞信指复星医药(02196-HK)与BioNTech设合营为利好 升目标价至60港元",
                "features": {
                    "keywords": [
                        "瑞信",
                        "复星医药",
                        "BioNTech",
                        "合营",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "快速扩产！BioNTech在新加坡设立区域总部和mRNA疫苗工厂",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "新加坡",
                        "区域总部",
                        "mRNA疫苗工厂"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "一天飙涨25% 游资、机构齐聚复星医药龙虎榜 私募人士提醒",
                "features": {
                    "keywords": [
                        "飙涨",
                        "游资",
                        "机构",
                        "龙虎榜",
                        "复星医药",
                        "私募人士提醒"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}